SRT3.XETRA Sartorius Aktiengesellschaft

Healthcare Health Care Equipment & Supplies XETRA Stock Exchange
557.16 EUR
Close of Nov 6, 2026
197.82 299.30
Market cap
EUR 19.4B
P/E
88.9x
P/B
6.79x
ROE
8.6%
Dividend yield
0.26%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is SRT3.XETRA undervalued?

Graham number

The Graham number of Sartorius Aktiengesellschaft cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sartorius Aktiengesellschaft fundamental analysis

No fundamental analysis for Sartorius Aktiengesellschaft yet.

Sartorius Aktiengesellschaft stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supp…

Full company profile